166480 — Corestemchemon Income Statement
0.000.00%
Last trade - 00:00- KR₩85bn
- KR₩128bn
- KR₩29bn
Annual income statement for Corestemchemon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 26,358 | 30,240 | 45,878 | 33,657 | 28,762 |
| Cost of Revenue | |||||
| Gross Profit | 4,950 | 7,986 | 15,244 | 3,493 | -1,118 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 33,368 | 40,790 | 53,848 | 55,229 | 49,093 |
| Operating Profit | -7,011 | -10,550 | -7,970 | -21,572 | -20,330 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18,011 | -4,425 | 3,407 | -17,676 | -31,303 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22,384 | -4,996 | 702 | -17,672 | -26,252 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -23,187 | -6,999 | -2,257 | -17,672 | -26,252 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23,187 | -6,999 | -2,257 | -17,672 | -26,252 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,475 | -444 | -74.5 | -760 | -1,171 |
| Dividends per Share |